Insmed Inc. buy UBS Group AG
Start price
29.05.24
/
50%
€46.00
Target price
29.05.25
€53.59
Performance (%)
33.70%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. With a performance of 33.70% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -3.226% | -3.226% | 72.662% |
| iShares Core DAX® | -0.437% | -5.315% | 1.438% |
| iShares Nasdaq 100 | -0.194% | 3.078% | 18.683% |
| iShares Nikkei 225® | -0.951% | -5.884% | 27.860% |
| iShares S&P 500 | -0.420% | 0.922% | 13.173% |
Comments by UBS_Group_AG for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at UBS Group AG from $46.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten